Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Prescription Drugs: Companies Typically Charge More in the United States Than in Canada

HRD-92-110 Published: Sep 30, 1992. Publicly Released: Oct 23, 1992.
Jump To:

Highlights

Pursuant to a congressional request, GAO provided information on the cost of prescription drug products, focusing on: (1) domestic and foreign price comparisons of identical prescription drugs; and (2) causes for documented price differentials.

Full Report

Full Report (42 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
Comparative analysisCost analysisDrugsFederal regulationsForeign governmentsHealth care cost controlPharmaceutical industryPharmacological researchPrice fixingPrice regulationPrescription drugs